664 766

Cited 0 times in

한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(Ⅰ):전반적 평가

Other Titles
 Feasibility of Korean Medication Algorithm for Bipolar Disorder( I ):Global Assessment 
Authors
 김찬형  ;  민경준  ;  신영철  ;  윤보현  ;  조현상  ;  전덕인  ;  김영기  ;  권준수  ;  박원명 
Citation
 Korean Journal of Psychopharmacology (대한정신약물학회지), Vol.16(3) : 225-233, 2005 
Journal Title
Korean Journal of Psychopharmacology(대한정신약물학회지)
ISSN
 1017-5717 
Issue Date
2005
MeSH
Bipolar disorder ; Korean Medication Algorithm ; Feasibility
Keywords
Bipolar disorder ; Korean Medication Algorithm ; Feasibility
Abstract
Objective : The Korean College of Neuro psychopharmacology and the Korean Academy of Schizophrenia developed the Korean algorithm project for bipolar disorder to aid clinical decisions. The purpose of this study was to assess the feasibility of Korean Medication Algorithm for Bipolar Disorder (KMAP-BP) in clinical settings in Korea.
Methods : A total of 126 bipolar patients were enrolled at 17 centers. Among them, 92 patients were treated according to the algorithm. All subjects were assessed over a 4-month period. Prescribing investigators were able to change the recommended treatment strategies of the algorithm if necessary.
Results : Overall ratings were favorable, with investigators stating that the overall quality of this algorithm was "good" or "no need to revise". Of manic patients, the majority (79%) showed treatment response (YMRS improvement ≥ 50%) at the first stage.
Conclusion : These results suggest that this algorithm can be useful in clinical practices. However, some problems should be solved in the next version of KMAP-BP.
Files in This Item:
T200500660.pdf Download
DOI
OAK-2005-04026
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Psychiatry (정신과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Chan Hyung(김찬형)
Cho, Hyun Sang(조현상) ORCID logo https://orcid.org/0000-0003-1019-9941
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/150972
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links